» Articles » PMID: 33320870

Olfactory Response As a Marker for Alzheimer's Disease: Evidence from Perceptual and Frontal Lobe Oscillation Coherence Deficit

Overview
Journal PLoS One
Date 2020 Dec 15
PMID 33320870
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

High-frequency oscillations of the frontal cortex are involved in functions of the brain that fuse processed data from different sensory modules or bind them with elements stored in the memory. These oscillations also provide inhibitory connections to neural circuits that perform lower-level processes. Deficit in the performance of these oscillations has been examined as a marker for Alzheimer's disease (AD). Additionally, the neurodegenerative processes associated with AD, such as the deposition of amyloid-beta plaques, do not occur in a spatially homogeneous fashion and progress more prominently in the medial temporal lobe in the early stages of the disease. This region of the brain contains neural circuitry involved in olfactory perception. Several studies have suggested that olfactory deficit can be used as a marker for early diagnosis of AD. A quantitative assessment of the performance of the olfactory system can hence serve as a potential biomarker for Alzheimer's disease, offering a relatively convenient and inexpensive diagnosis method. This study examines the decline in the perception of olfactory stimuli and the deficit in the performance of high-frequency frontal oscillations in response to olfactory stimulation as markers for AD. Two measurement modalities are employed for assessing the olfactory performance: 1) An interactive smell identification test is used to sample the response to a sizable variety of odorants, and 2) Electroencephalography data are collected in an olfactory perception task with a pair of selected odorants in order to assess the connectivity of frontal cortex regions. Statistical analysis methods are used to assess the significance of selected features extracted from the recorded modalities as Alzheimer's biomarkers. Olfactory decline regressed to age in both healthy and mild AD groups are evaluated, and single- and multi-modal classifiers are also developed. The novel aspects of this study include: 1) Combining EEG response to olfactory stimulation with behavioral assessment of olfactory perception as a marker of AD, 2) Identification of odorants most significantly affected in mild AD patients, 3) Identification of odorants which are still adequately perceived by mild AD patients, 4) Analysis of the decline in the spatial coherence of different oscillatory bands in response to olfactory stimulation, and 5) Being the first study to quantitatively assess the performance of olfactory decline due to aging and AD in the Iranian population.

Citing Articles

Functional and effective EEG connectivity patterns in Alzheimer's disease and mild cognitive impairment: a systematic review.

Paitel E, Otteman C, Polking M, Licht H, Nielson K Front Aging Neurosci. 2025; 17:1496235.

PMID: 40013094 PMC: 11861106. DOI: 10.3389/fnagi.2025.1496235.


Predicting the efficacy of donepezil intervention in Alzheimer's disease patients using regional homogeneity in the inferior orbitofrontal cortex.

Dai M, Guo Z, Xia H, Zhu H, Li J, Hou H Aging Clin Exp Res. 2024; 36(1):94.

PMID: 38630202 PMC: 11024046. DOI: 10.1007/s40520-023-02691-6.


Odor identification score as an alternative method for early identification of amyloidogenesis in Alzheimer's disease.

Igeta Y, Hemmi I, Yuyama K, Ouchi Y Sci Rep. 2024; 14(1):4658.

PMID: 38409432 PMC: 10897211. DOI: 10.1038/s41598-024-54322-3.


Brain electrophysiological recording during olfactory stimulation in mild cognitive impairment and Alzheimer disease patients: An EEG dataset.

Sedghizadeh M, Aghajan H, Vahabi Z Data Brief. 2023; 48:109289.

PMID: 37383823 PMC: 10294047. DOI: 10.1016/j.dib.2023.109289.


Uncovering the Correlation between COVID-19 and Neurodegenerative Processes: Toward a New Approach Based on EEG Entropic Analysis.

Cataldo A, Criscuolo S, De Benedetto E, Masciullo A, Pesola M, Schiavoni R Bioengineering (Basel). 2023; 10(4).

PMID: 37106622 PMC: 10135651. DOI: 10.3390/bioengineering10040435.


References
1.
Adler G, Brassen S, Jajcevic A . EEG coherence in Alzheimer's dementia. J Neural Transm (Vienna). 2003; 110(9):1051-8. DOI: 10.1007/s00702-003-0024-8. View

2.
Moraes E Silva M, Mercer P, Witt M, Pessoa R . Olfactory dysfunction in Alzheimer's disease Systematic review and meta-analysis. Dement Neuropsychol. 2018; 12(2):123-132. PMC: 6022986. DOI: 10.1590/1980-57642018dn12-020004. View

3.
Wang R, Wang J, Yu H, Wei X, Yang C, Deng B . Decreased coherence and functional connectivity of electroencephalograph in Alzheimer's disease. Chaos. 2014; 24(3):033136. DOI: 10.1063/1.4896095. View

4.
Chua X, Choo R, Ha N, Cheong C, Wee S, Yap P . Mapping modified Mini-Mental State Examination (MMSE) scores to dementia stages in a multi-ethnic Asian population. Int Psychogeriatr. 2018; 31(1):147-151. DOI: 10.1017/S1041610218000704. View

5.
Caminiti F, De Salvo S, De Cola M, Russo M, Bramanti P, Marino S . Detection of olfactory dysfunction using olfactory event related potentials in young patients with multiple sclerosis. PLoS One. 2014; 9(7):e103151. PMC: 4105616. DOI: 10.1371/journal.pone.0103151. View